Fidelity International’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161M Sell
416,341
-3,369
-0.8% -$1.25M 0.12% 181
2026
Q1
$123M Sell
419,710
-7,746
-2% -$2.55M 0.1% 212
2025
Q4
$150M Sell
427,456
-92,331
-18% -$31.2M 0.11% 196
2025
Q3
$168M Buy
519,787
+58,564
+13% +$18.2M 0.13% 177
2025
Q2
$179M Buy
461,223
+16,887
+4% +$6.79M 0.15% 158
2025
Q1
$193M Buy
444,336
+24,582
+6% +$9.87M 0.18% 139
2024
Q4
$155M Sell
419,754
-180,045
-30% -$75.3M 0.14% 170
2024
Q3
$312M Buy
599,799
+4,394
+0.7% +$2.35M 0.28% 95
2024
Q2
$323M Buy
595,405
+46,850
+9% +$24.8M 0.32% 90
2024
Q1
$284M Sell
548,555
-76,588
-12% -$38.1M 0.28% 97
2023
Q4
$295M Buy
625,143
+30,050
+5% +$13.9M 0.31% 88
2023
Q3
$259M Sell
595,093
-51,347
-8% -$23.3M 0.31% 90
2023
Q2
$287M Sell
646,440
-33,423
-5% -$15.4M 0.32% 86
2023
Q1
$313M Sell
679,863
-125,126
-16% -$59.5M 0.36% 79
2022
Q4
$413M Buy
804,989
+640
+0.1% +$325K 0.5% 48
2022
Q3
$365M Buy
804,349
+87,782
+12% +$42M 0.47% 52
2022
Q2
$346M Buy
716,567
+169,911
+31% +$84.1M 0.41% 60
2022
Q1
$269M Buy
546,656
+15,830
+3% +$7.24M 0.28% 100
2021
Q4
$246M Buy
530,826
+121,775
+30% +$51.2M 0.25% 102
2021
Q3
$152M Sell
409,051
-2,247
-0.5% -$854K 0.17% 150
2021
Q2
$157M Buy
411,298
+53,113
+15% +$20.3M 0.17% 154
2021
Q1
$129M Buy
358,185
+136,125
+61% +$43.8M 0.15% 170
2020
Q4
$71.3M Sell
222,060
-28,237
-11% -$8.67M 0.09% 234
2020
Q3
$67.2M Hold
250,297
0.08% 247
2020
Q2
$65.8M Sell
250,297
-27,343
-10% -$7.29M 0.09% 227
2020
Q1
$63M Sell
277,640
-178,113
-39% -$48.5M 0.1% 197
2019
Q4
$138M Buy
455,753
+37,274
+9% +$10.3M 0.19% 146
2019
Q3
$100M Sell
418,479
-23,051
-5% -$6.32M 0.15% 165
2019
Q2
$125M Buy
441,530
+77,018
+21% +$21M 0.19% 141
2019
Q1
$105M Sell
364,512
-227,419
-38% -$65.8M 0.16% 149
2018
Q4
$155M Sell
591,931
-24,211
-4% -$6.66M 0.28% 102
2018
Q3
$169M Buy
616,142
+62,533
+11% +$16.2M 0.25% 114
2018
Q2
$132M Buy
553,609
+39,845
+8% +$9.23M 0.2% 133
2018
Q1
$113M Sell
513,764
-296,846
-37% -$69.7M 0.31% 89
2017
Q4
$182M Buy
+810,610
New +$173M 0.51% 45
2017
Q3
Sell
-42,456
Closed -$7.99M 506
2017
Q2
$7.99M Sell
42,456
-10,747
-20% -$1.93M 0.02% 354
2017
Q1
$8.8M Sell
53,203
-23,847
-31% -$3.79M 0.02% 358
2016
Q4
$11.1M Buy
+77,050
New +$10.3M 0.03% 321
2016
Q3
Sell
-111,066
Closed -$14.6M 521
2016
Q2
$14.6M Sell
111,066
-28,496
-20% -$3.9M 0.05% 295
2016
Q1
$19.4M Hold
139,562
0.06% 248
2015
Q4
$19.5M Sell
139,562
-1,468,149
-91% -$202M 0.06% 255
2015
Q3
$225M Buy
1,607,711
+107,293
+7% +$16.1M 0.78% 35
2015
Q2
$246M Buy
1,500,418
+56,013
+4% +$8.95M 0.79% 33
2015
Q1
$223M Sell
1,444,405
-30,226
-2% -$4.3M 0.72% 36
2014
Q4
$185M Sell
1,474,631
-833
-0.1% -$103K 0.64% 44
2014
Q3
$176M Buy
+1,475,464
New +$169M 0.68% 39

Other funds holding ELV

Fidelity International's ELV Position: Q2 2026 in Review

Fidelity International reduced its Elevance Health (ELV) stake by 0.8% in Q2 2026, selling an estimated $1.25M and leaving 416,341 shares worth $161M. The position accounts for 0.12% of the portfolio, ranked #181.

Fidelity International first reported a position in ELV in Q3 2014 and has held it in 46 quarters since. The position peaked at $413M in Q4 2022. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fidelity International held 416,341 shares of Elevance Health worth $161M as of Q2 2026.
  • Fidelity International sold 3,369 Elevance Health shares in Q2 2026, an estimated $1.25M.
  • Elevance Health made up 0.12% of Fidelity International's portfolio in Q2 2026, its #181 holding.
  • Fidelity International first reported a position in Elevance Health in Q3 2014 and has held it in 46 quarters since.
  • Fidelity International's Elevance Health position peaked at $413M in Q4 2022.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.